SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905718-20-000998
Filing Date
2020-09-30
Accepted
2020-09-30 16:06:16
Documents
1
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 kintara_fm4sep302020.html 4  
1 kintara_fm4sep302020.xml 4 3274
  Complete submission text file 0000905718-20-000998.txt   4884
Mailing Address 2001-889 HOMER STREET VANCOUVER A1 V6B 5S3
Business Address
Praill Anthony Scott (Reporting) CIK: 0001332948 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37823 | Film No.: 201212319

Mailing Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130
Business Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130 (858) 350-4364
Kintara Therapeutics, Inc. (Issuer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences